Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
[18F] LBT-999 PET in Parkinson's Disease
NCT02393027Phase 1Terminated
- Sponsor
- University Hospital Tours
- Start
- Mar 2015
- Primary completion
- Nov 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label trial of 18f-lbt-999 in Parkinson's disease (PD) (2 arms), sponsored by University Hospital Tours. Primary endpoint: Binding potential of [18F] LBT-999 at 1 year. Started Mar 2015; status: terminated.
02
Drugs
18f-lbt-999
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on NCT02393027.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02393027.